{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:36:41Z","timestamp":1768077401835,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.biopha.2018.02.135","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T07:15:29Z","timestamp":1521702929000},"page":"821-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Phloretin either alone or in combination with duloxetine alleviates the STZ-induced diabetic neuropathy in rats"],"prefix":"10.1016","volume":"101","author":[{"given":"Mohamed","family":"Balaha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samah","family":"Kandeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Kabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2013","key":"10.1016\/j.biopha.2018.02.135_bib0005","first-page":"168039","article-title":"Diabetic neuropathy and oxidative stress: therapeutic perspectives","author":"Hosseini","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.biopha.2018.02.135_bib0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11910-014-0473-5","article-title":"Diabetic neuropathy: mechanisms, emerging treatments, and subtypes","volume":"14","author":"Albers","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.biopha.2018.02.135_bib0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4065\/mcp.2010.0681","article-title":"Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison","author":"Tanenberg","year":"2011","journal-title":"Mayo Clin. Proc. (Elsevier)"},{"issue":"12","key":"10.1016\/j.biopha.2018.02.135_bib0020","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diab. Care"},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1533-2500.2007.00164.x","article-title":"A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions","volume":"8","author":"Sadosky","year":"2008","journal-title":"Pain Pract."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diab. Care"},{"issue":"2014","key":"10.1016\/j.biopha.2018.02.135_bib0035","first-page":"674987","article-title":"Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets","author":"Sandireddy","year":"2014","journal-title":"Int. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.biopha.2018.02.135_bib0040","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2008-2534","article-title":"Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications","volume":"94","author":"Goldberg","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2018.02.135_bib0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2013.07.017","article-title":"Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms","volume":"719","author":"Sytze Van Dam","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2018.02.135_bib0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","article-title":"Diabetic neuropathy: cellular mechanisms as therapeutic targets","volume":"7","author":"Vincent","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.biopha.2018.02.135_bib0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/138161208784139774","article-title":"Role of advanced glycation end products in diabetic neuropathy","volume":"14","author":"Sugimoto","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2018.02.135_bib0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2010.11.013","article-title":"Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity","volume":"1370","author":"Padilla","year":"2011","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuint.2010.10.012","article-title":"7-ketocholesterol induces apoptosis in differentiated PC12 cells via reactive oxygen species-dependent activation of NF-\u03baB and Akt pathways","volume":"58","author":"Jang","year":"2011","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.biopha.2018.02.135_bib0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tem.2011.12.004","article-title":"Insulin resistance in the nervous system","volume":"23","author":"Kim","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.biopha.2018.02.135_bib0075","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1440-1681.2007.04729.x","article-title":"Role of macrophages in complications of type 2 diabetes","volume":"34","author":"Tesch","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/papr.12054","article-title":"Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy","volume":"14","author":"Snedecor","year":"2014","journal-title":"Pain Pract."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/SPC.0b013e32832b7df5","article-title":"Advances in the management of diabetic peripheral neuropathy","volume":"3","author":"Tesfaye","year":"2009","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"10","key":"10.1016\/j.biopha.2018.02.135_bib0090","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.pain.2014.08.020","article-title":"Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study","volume":"155","author":"Bouhassira","year":"2014","journal-title":"PAIN\u00ae"},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2012","key":"10.1016\/j.biopha.2018.02.135_bib0100","article-title":"Review of efficacy and safety of duloxetine 40\u201360\u202fmg once daily in patients with diabetic peripheral neuropathic pain","author":"Skljarevski","year":"2012","journal-title":"Pain Res. Treat."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/jdi.12361","article-title":"Efficacy and safety of 40\u202fmg or 60\u202fmg duloxetine in Japanese adults with diabetic neuropathic pain: results from a randomized, 52-week, open-label study","volume":"7","author":"Yasuda","year":"2016","journal-title":"J. Diab. Invest."},{"key":"10.1016\/j.biopha.2018.02.135_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.foodchem.2017.01.056","article-title":"Specific bioactive compounds in ginger and apple alleviate hyperglycemia in mice with high fat diet-induced obesity via Nrf2 mediated pathway","volume":"226","author":"Sampath","year":"2017","journal-title":"Food Chem."},{"key":"10.1016\/j.biopha.2018.02.135_bib0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/DDDT.S127010","article-title":"Phloretin exerts hypoglycemic effect in streptozotocin-induced diabetic rats and improves insulin resistance in vitro","volume":"11","author":"Shen","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11892-010-0095-5","article-title":"Turning glucosuria into a therapy: efficacy and safety with SGLT2 inhibitors","volume":"10","author":"Patel","year":"2010","journal-title":"Curr. Diab. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0125","doi-asserted-by":"crossref","DOI":"10.5339\/qfarc.2016.HBPP1906","article-title":"Bioactive components from ginger, tea and apple prevent protein glycation by trapping methylglyoxal with potential in alleviation of diabetic complications","volume":"2016","author":"Sang","year":"2016","journal-title":"Qatar Found. Annu. Res. Conf. Proc."},{"issue":"10","key":"10.1016\/j.biopha.2018.02.135_bib0130","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1111\/jcmm.13176","article-title":"Phloretin attenuates hyperuricemia-induced endothelial dysfunction through co-inhibiting inflammation and GLUT9-mediated uric acid uptake","volume":"21","author":"Liu","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2018.02.135_bib0135","first-page":"480","article-title":"Anti-inflammatory and immunosuppressive effect of phloretin","volume":"44","author":"Lu","year":"2009","journal-title":"Acta Pharm. Sin."},{"issue":"4","key":"10.1016\/j.biopha.2018.02.135_bib0140","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.fitote.2012.01.010","article-title":"Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy","volume":"83","author":"Kandhare","year":"2012","journal-title":"Fitoterapia"},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0145","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/jpet.104.070656","article-title":"Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats","volume":"311","author":"Iyengar","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2018.02.135_bib0150","first-page":"30","article-title":"Preventive effect of phloretin on components of glycoprotein changes in streptozotocin induced diabetic rats","volume":"2","author":"Nithiya","year":"2017","journal-title":"Int. J. Diab. Endocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2018.02.135_bib0155","first-page":"766","article-title":"Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats","volume":"42","author":"Anjaneyulu","year":"2004","journal-title":"Indian J. Exp. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2018.02.135_bib0160","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2018.02.135_bib0165","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","article-title":"Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide","volume":"28","author":"Fossati","year":"1982","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2018.02.135_bib0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-2275(20)42943-8","article-title":"Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions","volume":"11","author":"Burstein","year":"1970","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.02.135_bib0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum proteins by means of the biuret reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0190","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0006-291X(72)80218-3","article-title":"The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen","volume":"46","author":"Nishikimi","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1034","key":"10.1016\/j.biopha.2018.02.135_bib0195","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1039\/an9628700374","article-title":"The rapid determination of nitrate in fresh and saline waters","volume":"87","author":"Montgomery","year":"1962","journal-title":"Analyst"},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2018.02.135_bib0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000136485","article-title":"Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite","volume":"11","author":"Jollow","year":"1974","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2018.02.135_bib0210","series-title":"Bancroft\u2019s Theory and Practice of Histological Techniques","first-page":"104","author":"Suvarna","year":"2013"},{"issue":"3","key":"10.1016\/j.biopha.2018.02.135_bib0215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.mvr.2007.12.002","article-title":"Endoneurial microvascular pathology in feline diabetic neuropathy","volume":"75","author":"Estrella","year":"2008","journal-title":"Microvasc. Res."},{"issue":"5","key":"10.1016\/j.biopha.2018.02.135_bib0220","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ejp.586","article-title":"A selective \u03b12B adrenoceptor agonist (A-1262543) and duloxetine modulate nociceptive neurones in the medial prefrontal cortex, but not in the spinal cord of neuropathic rats","volume":"19","author":"Chu","year":"2015","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.biopha.2018.02.135_bib0225","first-page":"1","article-title":"Effects of duloxetine on the toll-like receptor 4 signaling pathway in spinal dorsal horn in a rat model of diabetic neuropathic pain","volume":"0","author":"Zhou","year":"2017","journal-title":"Pain Med."},{"issue":"3","key":"10.1016\/j.biopha.2018.02.135_bib0230","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4239\/wjd.v6.i3.432","article-title":"Diabetic neuropathic pain: physiopathology and treatment","volume":"6","author":"Schreiber","year":"2015","journal-title":"World J. Diab."},{"issue":"3","key":"10.1016\/j.biopha.2018.02.135_bib0235","first-page":"301","article-title":"Aqueous extract of Zizyphus jujuba fruit attenuates glucose induced neurotoxicity in an in vitro model of diabetic neuropathy","volume":"18","author":"Kaeidi","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2018.02.135_bib0240","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14740338.2010.484418","article-title":"Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials","volume":"9","author":"Hall","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0245","first-page":"1304","article-title":"Efficacy and safety of duloxetine compared with placebo for diabetic neuropathy pain: meta-analysis","volume":"5","author":"Hassan","year":"2016","journal-title":"Int. J. Med. Dent. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2337\/dc06-0947","article-title":"Does treatment with duloxetine for neuropathic pain impact glycemic control?","volume":"30","author":"Hardy","year":"2007","journal-title":"Diab. Care"},{"issue":"6","key":"10.1016\/j.biopha.2018.02.135_bib0255","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S1734-1140(13)71521-4","article-title":"Mechanisms and pharmacology of diabetic neuropathy\u2013experimental and clinical studies","volume":"65","author":"Zychowska","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2018.02.135_bib0260","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12072-017-9840-z","article-title":"The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients","volume":"12","author":"Singh","year":"2018","journal-title":"Hepatol. Int."},{"issue":"6","key":"10.1016\/j.biopha.2018.02.135_bib0270","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jdiacomp.2017.01.024","article-title":"Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes","volume":"31","author":"Mantovani","year":"2017","journal-title":"J. Diab. Complications"},{"key":"10.1016\/j.biopha.2018.02.135_bib0275","first-page":"1","article-title":"Health effects of phloretin: from chemistry to medicine","author":"Behzad","year":"2017","journal-title":"Phytochem. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2018.02.135_bib0280","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.jnutbio.2014.07.007","article-title":"Phloretin promotes adipocyte differentiation in vitro and improves glucose homeostasis in vivo","volume":"25","author":"Shu","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"12\/13","key":"10.1016\/j.biopha.2018.02.135_bib0285","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1055\/s-0043-106050","article-title":"Natural products as lead compounds for sodium glucose cotransporter (SGLT) inhibitors","volume":"83","author":"Blaschek","year":"2017","journal-title":"Planta Med."},{"issue":"6","key":"10.1016\/j.biopha.2018.02.135_bib0290","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0295","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1194\/jlr.M021188","article-title":"Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation","volume":"53","author":"Cermenati","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2018.02.135_bib0300","first-page":"1","article-title":"Duloxetine reduces oxidative stress, apoptosis, and Ca2+ entry through modulation of TRPM2 and TRPV1 channels in the hippocampus and dorsal root ganglion of rats","author":"Demirda\u015f","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2018.02.135_bib0305","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jns.2016.09.059","article-title":"Pretreated duloxetine protects hippocampal CA1 pyramidal neurons from ischemia-reperfusion injury through decreases of glial activation and oxidative stress","volume":"370","author":"Lee","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2018.02.135_bib0310","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.freeradbiomed.2011.09.007","article-title":"Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK\/Nrf2 pathway and protects against oxidative stress","volume":"51","author":"Yang","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2018.02.135_bib0315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11892-016-0727-5","article-title":"Inflammation as a therapeutic target for diabetic neuropathies","volume":"16","author":"Pop-Busui","year":"2016","journal-title":"Curr. Diab. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2018.02.135_bib0320","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.joms.2016.01.022","article-title":"Role of collagen conduit with duloxetine and\/or pregabalin in the management of partial peripheral nerve injury","volume":"74","author":"Khan","year":"2016","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.biopha.2018.02.135_bib0325","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jad.2012.08.007","article-title":"Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds","volume":"145","author":"Fornaro","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.biopha.2018.02.135_bib0330","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/NDT.S16382","article-title":"Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg\/day: a preliminary observation","volume":"7","author":"Fornaro","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2014","key":"10.1016\/j.biopha.2018.02.135_bib0335","article-title":"Leukocyte production of inflammatory mediators is inhibited by the antioxidants phloretin, silymarin, hesperetin, and resveratrol","author":"Fordham","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0340","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.intimp.2015.04.024","article-title":"Phloretin ameliorates chemokines and ICAM-1 expression via blocking of the NF-\u03baB pathway in the TNF-\u03b1-induced HaCaT human keratinocytes","volume":"27","author":"Huang","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2018.02.135_bib0345","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/11539240-000000000-00000","article-title":"Duloxetine: clinical pharmacokinetics and drug interactions","volume":"50","author":"Knadler","year":"2011","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.135_bib0350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/biof.190","article-title":"Dual effects of phloretin on aflatoxin B1 metabolism: activation and detoxification of aflatoxin B1","volume":"38","author":"Gao","year":"2012","journal-title":"Biofactors"},{"issue":"2","key":"10.1016\/j.biopha.2018.02.135_bib0355","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00186256","article-title":"Phloretin affects the fast potassium channels in frog nerve fibres","volume":"20","author":"Klusemann","year":"1991","journal-title":"Eur. Biophys. J."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218305250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218305250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:27:43Z","timestamp":1760095663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218305250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":71,"alternative-id":["S0753332218305250"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.02.135","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phloretin either alone or in combination with duloxetine alleviates the STZ-induced diabetic neuropathy in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.02.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}